BioSpace News Archive

Jazz Pharmaceuticals plc and Zymeworks Inc. announced that Jazz and Zymeworks’ subsidiary, Zymeworks BC Inc., have entered into an exclusive licensing agreement under which Jazz will acquire development and commercialization rights to Zymeworks’ zanidatamab across all indications in the United States, Europe, Japan and all other territories except for those Asia/Pacific territories previously licensed by Zymeworks.

Inversago Pharma Inc. announced the appointment of two new board members: Ed Mathers, BSc, General Partner at New Enterprise Associates and Nanna Lüneborg, PhD, MBA, General Partner at Forbion.

Triumvira Immunologics announced a multi-year agreement with AmplifyBio to use its facilities in South San Francisco, Calif.

Ayala Pharmaceuticals, Inc. and Advaxis, Inc. announced that they have entered into a definitive merger agreement.

NovaBay® Pharmaceuticals, Inc. announces that management will present a company overview at the LD Micro Main Event XV on Wednesday, October 26 at 8:00 a.m. Pacific time.

Tango Therapeutics, Inc. today announced that three abstracts have been selected for presentation as posters at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, being held in Barcelona, Spain from October 26-28, 2022.

Miromatrix Medical Inc. today announced that CEO Jeff Ross will be a keynote speaker at BioFabUSA’s 2022 Fall Summit from the Advanced Regenerative Manufacturing Institute (ARMI).

Kamada Ltd. announced that the Company was awarded an extension of an existing tender from the Canadian Blood Services for the supply of four IgG products, CYTOGAM®, HEPAGAM®, VARIZIG® and WINRHO® SDF, for an additional three years for an approximate total value of $22 million.

VIB, Flanders’ leading life sciences institute, and Surface Oncology today announced jointly the publication of a study entitled, “Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27: Cell Reports,” in Cell Reports, a leading scientific journal.

Tiziana Life Sciences Ltd will be participating in The ThinkEquity Conference, which will take place on October 26, 2022 at The Mandarin Oriental Hotel in New York.